Literature DB >> 26620950

Surgical management of secondary hyperparathyroidism: how to effectively reduce recurrence at the time of primary surgery.

D Xu1, Y Yin2, L Hou3, W Dai4.   

Abstract

BACKGROUND: Successful parathyroidectomy (PTX) often results in a dramatic drop in the parathyroid hormone (PTH) levels, relieves the patient from clinical symptoms, and reduces mortality. Although PTX is generally a successful treatment for progressive secondary hyperparathyroidism (SHPT) patients subjected to surgery, a significant proportion develops recurrent SHPT following PTX. KEY MESSAGE: SHPT requiring PTX occurs more commonly in progressive chronic kidney disease and in long-term lithium therapy. Operative approaches include subtotal PTX, total PTX with or without autotransplantation, and possible thymectomy. Each approach has its proponents, advantages, and disadvantages. Although PTX offers the highest percentage cure for SHPT, compared to all other medical and surgical treatment, recurrent hyperparathyroidism can be observed in some patients dependent on follow-up time. A literature review and analysis of recent data regarding how to reduce recurrence of SHPT at the time of primary surgery was performed. The current literature and our own experience in the field have confirmed that pre-operative imaging, thymectomy, stereo magnifier, and surgical procedure may effectively reduce recurrence of SHPT at the time of primary surgery.

Entities:  

Keywords:  Hyperparathyroidism; Parathyroidectomy; Renal hyperparathyroidism; Secondary hyperparathyroidism; Thymectomy

Mesh:

Year:  2015        PMID: 26620950     DOI: 10.1007/s40618-015-0410-8

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

1.  [Focal proliferation in reactive hyperplastic parathyroid tissue in end-stage renal failure--implication for autotransplantation after total parathyroidectomy].

Authors:  H Hörandner; E Mürzl; U Neyer; S Breiteneder-Geleff; B Niederle; A Haid; G Breitfellner
Journal:  Wien Klin Wochenschr       Date:  2000-04-21       Impact factor: 1.704

2.  Transplantation of the parathyroid glands in man: clinical indications and results.

Authors:  S A Wells; J C Gunnells; J D Shelburne; A B Schneider; L M Sherwood
Journal:  Surgery       Date:  1975-07       Impact factor: 3.982

3.  Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Nobuaki Uno; Toyonori Tsuzuki; Takahisa Hiramitsu; Norihiko Goto; Takaharu Nagasaka; Yoshihiko Watarai; Kazuharu Uchida
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

4.  Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism.

Authors:  Mira Milas; Collin J Weber
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

Review 5.  The surgical management of renal hyperparathyroidism.

Authors:  Catherine Madorin; Randall P Owen; William D Fraser; Phillip K Pellitteri; Brian Radbill; Alessandra Rinaldo; Raja R Seethala; Ashok R Shaha; Carl E Silver; Matthew Y Suh; Barrie Weinstein; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-20       Impact factor: 2.503

6.  Total parathyroidectomy in treatment of secondary (renal) hyperparathyroidism.

Authors:  C S Ogg
Journal:  Br Med J       Date:  1967-11-11

7.  Role of pre-operative imaging using 99mTc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy.

Authors:  David Fuster; Juan Ybarra; Jaime Ortin; José-Vicente Torregrosa; Rosa Gilabert; Xavier Setoain; Pilar Paredes; Joan Duch; Francesca Pons
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-11       Impact factor: 9.236

8.  Multiglandular disease in seemingly sporadic primary hyperparathyroidism revisited: where are we in the early 1990s? A plea against unilateral parathyroid exploration.

Authors:  C A Proye; B Carnaille; J P Bizard; J L Quievreux; M Lecomte-Houcke
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

9.  Value of dual-phase (99m)Tc-sestamibi scintigraphy with neck and thoracic SPECT/CT in secondary hyperparathyroidism.

Authors:  Jigang Yang; Ruirui Hao; Leilei Yuan; Chunlin Li; Jue Yan; Lishi Zhen
Journal:  AJR Am J Roentgenol       Date:  2014-01       Impact factor: 3.959

10.  Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial.

Authors:  Katja Schlosser; Johannes A Veit; Stefan Witte; Emilio Domínguez Fernández; Norbert Victor; Hans-Peter Knaebel; Christoph M Seiler; Matthias Rothmund
Journal:  Trials       Date:  2007-09-18       Impact factor: 2.279

View more
  6 in total

Review 1.  [Management of secondary hyperparathyroidism-current impact of parathyroidectomy].

Authors:  Emanuel Zitt; Karl Lhotta
Journal:  Wien Med Wochenschr       Date:  2016-02-25

2.  Recurrent primary hyperparathyroidism due to Type 1 parathyromatosis.

Authors:  Monica Jain; David L Krasne; Frederick R Singer; Armando E Giuliano
Journal:  Endocrine       Date:  2016-10-14       Impact factor: 3.633

3.  Combined BRAFV600E analysis and 99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation.

Authors:  A Campennì; R M Ruggeri; M Siracusa; S A Pignata; F Di Mauro; A Vento; F Trimarchi; S Baldari
Journal:  J Endocrinol Invest       Date:  2018-03-16       Impact factor: 4.256

4.  Use of 99mTc-sestamibi SPECT/CT imaging in predicting the degree of pathological hyperplasia of the parathyroid gland: semi-quantitative analysis.

Authors:  Junhao Ma; Jun Yang; Chuanzhi Chen; Yimin Lu; Zhuochao Mao; Haohao Wang; Yan Yang; Zhongqi Li; Weibin Wang; Lisong Teng
Journal:  Quant Imaging Med Surg       Date:  2021-10

5.  Safety and effectiveness of reoperation for persistent or recurrent drug refractory secondary hyperparathyroidism.

Authors:  Lei Zhu; Feng Cheng; Xi Zhu; Bin Zhou; Yonghong Xu; Yong Wu; Chuxiao Shao
Journal:  Gland Surg       Date:  2020-04

6.  Surgical Outcomes of Subtotal Parathyroidectomy for Renal Hyperparathyroidism.

Authors:  Min Song Kim; Gheun-Ho Kim; Chang Hwa Lee; Joon-Sung Park; Ji Young Lee; Kyung Tae
Journal:  Clin Exp Otorhinolaryngol       Date:  2020-02-21       Impact factor: 3.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.